Plasma Metabolite Markers of Parkinson’s Disease and Atypical Parkinsonism

Differentiating between Parkinson’s disease (PD) and the atypical Parkinsonian disorders of multiple system atrophy (MSA) and progressive supranuclear palsy (PSP) is difficult clinically due to overlapping symptomatology, especially at early disease stages. Consequently, there is a need to identify...

Descripción completa

Detalles Bibliográficos
Autores principales: Pathan, Meerakhan, Wu, Junfang, Lakso, Hans-Åke, Forsgren, Lars, Öhman, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706715/
https://www.ncbi.nlm.nih.gov/pubmed/34940618
http://dx.doi.org/10.3390/metabo11120860

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8706715/
https://www.ncbi.nlm.nih.gov/pubmed/34940618
http://dx.doi.org/10.3390/metabo11120860

Ejemplares similares